中国临床药学杂志

参考文献

[1]IMENSHAHIDI M,HOSSEINZADEH H.Berberine and barberry(Berberis vulgaris):a clinical review[J].Phytother Res,2019,33(3):504.

[2]OCH A,PODGORSKI R,NOWAK R.Biological activity of berberine-a summary update[J].Toxins,2020,12(11):713.

[3]WANG N,TAN H Y,LI L,et al.Berberine and Coptidis Rhizoma as potential anticancer agents:recent updates and future perspectives[J].J Ethnopharmacol,2015,176:35.

[4]LU Q K,FU Y F,LI H.Berberine and its derivatives represent as the promising therapeutic agents for inflammatory disorders[J].Pharmacol Rep,2022,74(2):297.

[5]FENG X J,SUREDA A,JAFARI S,et al.Berberine in cardiovascular and metabolic diseases:from mechanisms to therapeutics[J].Theranostics,2019,9(7):1923.

[6]SUN S N,ZHANG X J,XU M R,et al.Berberine downregulates CDC6 and inhibits proliferation via targeting JAK-STAT3 signaling in keratinocytes[J].Cell Death Dis,2019,10(4):274.

[7]MITTAL A,TABASUM S,SINGH R P.Berberine in combination with doxorubicin suppresses growth of murine melanoma B16F10cells in culture and xenograft[J].Phytomedicine,2014,21(3):340.

[8]ANDOH T,YOSHIHISA Y, REHMAN M U,et al.Berberine induces anti-atopic dermatitis effects through the downregulation of cutaneous EIF3F and MALT1 in NC/Nga mice with atopy-like dermatitis[J].Biochem Pharmacol,2021,185:114439.

[9]LIU J F, LAI K C,PENG S F,et al.Berberine inhibits human melanoma A375.S2 cell migration and invasion via affecting the FAK,uPA,and NF-κB signaling pathways and inhibits PLX4032resistant A375.S2 cell migration in vitro[J].Molecules,2018,23(8):2019.

[10]KIM S,KIM Y,KIM J E,et al.Berberine inhibits TPA-induced MMP-9 and IL-6 expression in normal human keratinocytes[J].Phytomedicine,2008,15(5):340.

[11]RONDANELLI M, RIVA A,PETRANGOLINI G,et al.Berberine phospholipid is an effective insulin sensitizer and improves metabolic and hormonal disorders in women with polycystic ovary syndrome:a one-group pretest-post-test explanatory study[J].Nutrients,2021,13(10):3665.

[12]JIANG W,LI S L,CHEN X G, et al.Berberine protects immortalized line of human melanocytes from H2O2-induced oxidative stress via activation of Nrf2 and Mitf signaling pathway[J].J Dermatol Sci,2019,94(1):236.

[13]SONG Y C,LEE Y,KIM H M,et al.Berberine regulates melanin synthesis by activating PI3K/AKT,ERK and GSK3β in B16F10melanoma cells[J].Int J Mol Med,2015,35(4):1011.

[14]KOU Y,LI L,LI H,et al.Berberine suppressed epithelial mesenchymal transition through cross-talk regulation of PI3 K/AKTand RARα/RARβ in melanoma cells[J].Biochem Biophys Res Commun,2016,479(2):290.

[15]FANG J P,HUANG X,YANG Y,et al.Berberine-photodynamic induced apoptosis by activating endoplasmic reticulum stressautophagy pathway involving CHOP in human malignant melanoma cells[J].Biochem Biophys Res Commun,2021,552:183.

[16]STRASHILOV S,YORDANOV A.Aetiology and pathogenesis of cutaneous melanoma:current concepts and advances[J].Int J Mol Sci,2021,22(12):6395.

[17]REN M,YANG L H,LI D X,et al.Cell cycle regulation by berberine in human melanoma A375 cells[J].Bull Exp Biol Med,2020,169(4):491.

[18]BURGEIRO A, GAJATE C,DAKIR E L H,et al.Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberineinduced apoptosis in human melanoma cells[J].Anticancer Drugs,2011,12(6):507.

[19]WANG X T,GONG Q Y,SONG C F,et al.Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways[J].Toxicol Appl Pharmacol,2021,418:115484.

[20]WALDMAN A,SCHMULTS C.Cutaneous squamous cell carcinoma[J].Hematol Oncol Clin North Am,2019,33(1):1.

[21]LI D X,ZHANG J,ZHANG Y,et al.Inhibitory effect of berberine on human skin squamous cell carcinoma A43 1 cells[J].Genet Mol Res,2015,14(3):10553.

[22]LI H G,ZHANG Z,ZHANG H,et al.Update on the pathogenesis and therapy of atopic dermatitis[J].Clin Rev Allergy Immunol,2021,61(3):324.

[23]TSANG M S,JIAO D L,CHAN B C,et al.Anti-inflammatory activities of pentaherbs formula,berberine,Gallic acid and chlorogenic acid in atopic dermatitis-like skin inflammation[J].Molecules,2016,21(4):519.

[24]NASSAU S,FONACIER L.Allergic contact dermatitis[J].Med Clin N Am,2020,104(1):61.

[25]LI W H,LIU F X,WANG J,et al.microRNA-21-mediated inhibition of mast cell degranulation involved in the protective effect of berberine on 2,4-dinitrofluorobenzene-induced allergic contact dermatitis in rats via p38 pathway[J].Inflammation,2018,41(2):689.

[26]SARAMA R,MATHARU P K,ABDULDAIEM Y,et al.In vitro disease models for understanding psoriasis and atopic dermatitis[J].Front Bioeng Biotechnol,2022,10:803218.

[27]NGUYEN L T H,CHOI M J,SHIN H M,et al.Coptisine alleviates imiquimod-induced psoriasis-like skin lesions and anxiety-like behavior in mice[J].Molecules,2022,27(4):1412.

[28]FREAG M S,TORKY A S,NASRA M M,et al.Liquid crystalline nanoreservoir releasing a highly skin-penetrating berberine oleate complex for psoriasis management[J].Nanomed-Nanotechnol Biol Med,2019,14(8):931.

[29]JIANG H,LI C Y.Common pathogenesis of acne vulgaris and atherosclerosis[J].Inflammation,2019,42(1):1.

[30]NAM C,KIM S,SIM Y,et al.Anti-acne effects of Oriental herb extracts:a novel screening method to select anti-acne agents[J].Skin Pharmacol Appl Skin Physiol,2003,16(2):84.

[31]LEE J W,KANG Y J,CHOI H K,et al.Fractionated Coptischinensis extract and its bioactive component suppress Propionibacterium acnes-stimulated inflammation in human keratinocytes[J].J Microbiol Bio technol,2018,28(6):839.

[32]HIGAKI S,NAKAMURA M,MOROHASHI M,et al.Anti-lipase activity of kampo formulations,coptidis rhizoma and its alkaloids against propionibacterium acnes[J].J Dermatol,1996,23(5):310.

[33]PASCALAU V,BOGDAN C,PALL E,et al.Development of BSA gel/Pectin/Chitosan polyelectrolyte complex microcapsules for Berberine delivery and evaluation of their inhibitory effect on Cutibacterium acnes[J].React Funct Polym,2020,147:104457.

[34]FRISOLI M L,ESSIEN K,HARRIS J E.Vitiligo:mechanisms of pathogenesis and treatment[J].Annu Rev Immunol,2020,38:621.

[35]MIR-PALOMO S,NáCHER A,OFELIA VILA BUSóM A,et al.Baicalin and berberine ultradeformable vesicles as potential adjuvant in vitiligo therapy[J].Colloids Surf B Biointerfaces,2019,175:654.

[36]范平.91例舌舐皮炎治疗及随访分析[J].临床皮肤科杂志,2009,38(3):147.

[37]钟惠燕.0.1%黄连素液治疗80例新生儿脓疱疮的疗效观察[J].中外医疗2012,31(13):11.

[38]孟祖东,杜天平,鲁英.2%呋西地酸乳膏与0.05%黄连素溶液洗浴治疗脓疱疮的疗效观察[J].中国现代药物应用,2010,4(13):80.

[39]陈高,金湛,王曦,等.黄连解毒汤合黄连素辅治带状疱疹疗效分析[J].实用中医药杂志,2019,35(8):959.

[40]季姗姗.黄连素湿敷治疗面部湿疹皮炎156例疗效观察[C]//全国中西医结合变态反应第二次学术会议暨中国中西医结合学会变态反应专业委员会成立大会论文汇编.2004:202.

[41]TORKY A S,FREAG M S,NASRA M M A,et al.Novel skin penetrating berberine oleate complex capitalizing on hydrophobic ion pairing approach[J].Int J Pharm,2018,549(1-2):76.

[42]NIU J X,YUAN M,CHEN C C,et al.Berberine-loaded thiolated pluronic F127 polymeric micelles for improving skin permeation and retention[J].Int J Nanomedicine,2020,15:9987.